STEPHANE DEGRAFF: Open Payments
NPI 1659934933 · EAST CHICAGO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 19 payments from 6 companies in 2025. Trend: 2023 $1,602 · 2024 $94 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $343 |
| Teva Pharmaceuticals USA, Inc. | 4 | $181 |
| Axsome Therapeutics, Inc. | 1 | $48 |
| ABBVIE INC. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Alkermes, Inc. | 1 | $14 |
Products named: COBENFY, UZEDY, Auvelity, VRAYLAR, INVEGA SUSTENNA, ARISTADA.
Industry payments across IN — which companies pay providers there.
